1
|
Bou G, Cerveró G, Domínguez MA, Quereda C
and Martínez-Beltrán J: Characterization of a nosocomial outbreak
caused by a multiresistant Acinetobacter baumannii strain with a
carbapenem-hydrolyzing enzyme: High-level carbapenem resistance in
A. Baumannii is not due solely to the presence of beta-lactamases.
J Clin Microbiol. 38:3299–3305. 2000.PubMed/NCBI
|
2
|
Levin AS: Multiresistant Acinetobacter
infections: A role for sulbactam combinations in overcoming an
emerging worldwide problem. Clin Microbiol Infect. 8:144–153. 2002.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Gulen TA, Guner R, Celikbilek N, Keske S
and Tasyaran M: Clinical importance and cost of bacteremia caused
by nosocomial multi drug resistant acinetobacter baumannii. Int J
Infect Dis. 38:32–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
4
|
Shih MJ, Lee NY, Lee HC, Chang CM, Wu CJ,
Chen PL, Ko NY and Ko WC: Risk factors of multidrug resistance in
nosocomial bacteremia due to Acinetobacter baumannii: A case
control study. J Microbiol Immunol Infect. 41:118–123.
2008.PubMed/NCBI
|
5
|
Tas T, Kocoglu E, Mengeloglu Z, Bucak O
and Karabörk S: Investigation of in-vitro susceptibility of
multidrug-resistant Acinetobacter baumannii strains isolated from
clinical specimens to tigecycline. Bosn J Basic Med Sci.
13:266–270. 2013.PubMed/NCBI
|
6
|
Minandri F, D'Arezzo S, Antunes LC,
Pourcel C, Principe L, Petrosillo N and Visca P: Evidence of
diversity among epidemiologically related carbapenemase-producing
Acinetobacter baumannii strains belonging to international clonal
lineage II. J Clin Microbiol. 50:590–597. 2012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Castanheira M, Wanger A, Kruzel M,
Deshpande LM and Jones RN: Emergence and clonal dissemination of
OXA-24- and OXA-58-Producing Acinetobacter baumannii Strains in
Houston, Texas: Report from the SENTRY Antimicrobial Surveillance
Program. J Clin Microbiol. 46:3179–3180. 2008. View Article : Google Scholar : PubMed/NCBI
|
8
|
Lu PL, Siu LK, Chen TC, Ma L, Chiang WG,
Chen YH, Lin SF and Chen TP: Methicillin-resistant Staphylococcus
aureus and Acinetobacter baumannii on computer interface surfaces
of hospital wards and association with clinical isolates. BMC
Infect Dis. 9:1642009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Clinical and Laboratory Standards
Institute, . Performance Standards for Antimicrobial Susceptibility
Testing: Twenty-Second Informational Supplement M100-S22. CLSI.
32:64–65. 2012.
|
10
|
Koeleman JG, Stoof J, Biesmans DJ,
Savelkoul PH and Vandenbroucke-Grauls CM: Comparison of amplified
ribosomal DNA restriction analysis, random amplified polymorphic
DNA analysis and amplified fragment length polymorphism
fingerprinting for identification of Acinetobacter genomic species
and typing of Acinetobacter baumannii. J Clin Microbiol.
36:2522–2529. 1998.PubMed/NCBI
|
11
|
Hoban DJ, Bouchillon SK and Dowzicky MJ:
Antimicrobial susceptibility of extended-spectrum beta-lactamase
producers and multidrug-resistant Acinetobacter baumannii
throughout the United States and comparative in vitro activity of
tigecycline, a new glycylcycline antimicrobial. Diagn Microbiol
Infect Dis. 57:423–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
12
|
López-Alvarez B, Martín-Laez R, Fariñas
MC, Paternina-Vidal B, García-Palomo JD and Vázquez-Barquero A:
Multidrug-resistant Acinetobacter baumannii ventriculitis:
Successful treatment with intraventricular colistin. Acta Neurochir
(Wien). 151:1465–1472. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Kwa AL, Loh C, Low JG, Kurup A and Tam VH:
Nebulized colistin in the treatment of pneumonia due to
multidrug-resistant Acinetobacter baumannii and Pseudomonas
aeruginosa. Clin Infect Dis. 41:754–757. 2005. View Article : Google Scholar : PubMed/NCBI
|
14
|
Ho CM, Ho MW, Chi CY, Lin CD, Lin CW,
Tseng SP, Teng LJ, Chang HY, Chang HL, Chang YF, et al: Repeated
colonization by multi-drug-resistant Acinetobacter calcoaceticus-A.
Baumannii complex and changes in antimicrobial susceptibilities in
surgical intensive care units. Surg Infect (Larchmt). 14:43–48.
2013. View Article : Google Scholar : PubMed/NCBI
|
15
|
Celik IH, Oguz SS, Demirel G, Erdeve O and
Dilmen U: Outcome of ventilator-associated pneumonia due to
multidrug-resistant Acinetobacter baumannii and Pseudomonas
aeruginosa treated with aerosolized colistin in neonates: A
retrospective chart review. Eur J Pediatr. 171:311–316. 2012.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Moland ES, Craft DW, Hong SG, Kim SY,
Hachmeister L, Sayed SD and Thomson KS: In vitro activity of
tigecycline against multidrug-resistant Acinetobacter baumannii and
selection of tigecycline-amikacin synergy. Antimicrob Agents
Chemother. 52:2940–2942. 2008. View Article : Google Scholar : PubMed/NCBI
|
17
|
D'Arezzo S, Capone A, Petrosillo N, Visca
P, GRAB, Ballardini M, Bartolini S, Bordi E, Di Stefano A, Galiè M,
et al: Epidemic multidrug-resistant Acinetobacter baumannii related
to European clonal types I and II in Rome (Italy). Clin Microbiol
Infect. 15:347–357. 2009. View Article : Google Scholar : PubMed/NCBI
|
18
|
Garnacho-Montero J and Amaya-Villar R:
Multiresistant Acinetobacter baumannii infections: Epidemiology and
management. Curr Opin Infect Dis. 23:332–339. 2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Hou C and Yang F: Drug-resistant gene of
blaOXA-23, blaOXA-24, blaOXA-51 and blaOXA-58 in Acinetobacter
baumannii. Int J Clin Exp Med. 8:13859–13863. 2015.PubMed/NCBI
|
20
|
Poirel L, Pitout JD and Nordmann P:
Carbapene-mases: Molecular diversity and clinical consequences.
Future Microbio. 2:501–512. 2007. View Article : Google Scholar
|
21
|
Sinha M and Srinivasa H: Mechanisms of
resistance to carbapenems in meropenem- resistant Acinetobacter
isolates from clinical samples. Ind J Med Microbiol. 25:121–125.
2008. View Article : Google Scholar
|
22
|
Chretien FC and Dubois R: Effect of
nomegestrol acetate on spinability, ferning and mesh dimension of
midcycle cervical mucus. Contraception. 43:55–65. 1991. View Article : Google Scholar : PubMed/NCBI
|
23
|
Radberg G, Nilsson LE and Svensson S:
Development of quinolone-imipenem cross resistance in Pseudomonas
aeruginosa during exposure to ciprofloxacin. Antimicrob Agents
Chemother. 34:2142–2147. 1990. View Article : Google Scholar : PubMed/NCBI
|
24
|
Barclay ML, Begg EJ, Chambers ST and
Peddie BA: The effect of aminoglycoside-induced adaptive resistance
on the antibacterial activity of other antibiotics against
Pseudomonas aeruginosa in vitro. J Antimicrob Chemother.
38:853–858. 1996. View Article : Google Scholar : PubMed/NCBI
|
25
|
Prasad SV, Ballal M and Shivananda PG:
Induction of resistance to fluoroquinolones in clinical and
environmental isolates of Pseudomonas aeruginosa. Indian J Pathol
Microbiol. 50:94–96. 2007.PubMed/NCBI
|
26
|
De Vecchi E, Nicola L, Zucchetti E and
Drago L: In vitro induction of resistance by tissue concentrations
of azithromycin, clarithromycin, cefixime and
amoxicillin/clavulanate in clinical isolates of Streptococcus
pyogenes. J Chemother. 18:379–388. 2006. View Article : Google Scholar : PubMed/NCBI
|
27
|
Miller K, O'Neill AJ and Chopra I:
Response of Escherichia coli hypermutators to selection pressure
with antimicrobial agents from different classes. J Antimicrob
Chemother. 49:925–934. 2002. View Article : Google Scholar : PubMed/NCBI
|
28
|
Tripodi MF, Durante-Mangoni E, Fortunato
R, Utili R and Zarrilli R: Comparative activities of colistin,
rifampicin, imipenem and sulbactam/ampicillin alone or in
combination against epidemic multidrug-resistant Acinetobacter
baumannii isolates producing OXA-58 carbapenemases. Int J
Antimicrob Agents. 30:537–540. 2007. View Article : Google Scholar : PubMed/NCBI
|
29
|
Jeon BC, Jeong SH, Bae IK, Kwon SB, Lee K,
Young D, Lee JH, Song JS and Lee SH: Investigation of a nosocomial
outbreak of imipenem-resistant Acinetobacter baumannii producing
the OXA-23 beta-lactamase in Korea. J Clin Microbiol. 43:2241–2245.
2005. View Article : Google Scholar : PubMed/NCBI
|
30
|
Chiu CH, Lee HY, Tseng LY, Chen CL, Chia
JH, Su LH and Liu SY: Mechanisms of resistance to ciprofloxacin,
ampicillin/sulbactam and imipenem in Acinetobacter baumannii
clinical isolates in Taiwan. Int J Antimicrob Agents. 35:382–386.
2010. View Article : Google Scholar : PubMed/NCBI
|
31
|
Liu YH, Kuo SC, Lee YT, Chang IC, Yang SP,
Chen TL and Fung CP: Amino acid substitutions of quinolone
resistance determining regions in GyrA and ParC associated with
quinolone resistance in Acinetobacter baumannii and Acinetobacter
genomic species 13TU. J Microbiol Immunol Infect. 45:108–112. 2012.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Wieczorek P, Sacha P, Hauschild T,
Zorawski M, Krawczyk M and Tryniszewska E: Multidrug resistant
Acinetobacter baumannii-the role of AdeABC (RND family) efflux pump
in resistance to antibiotics. Folia Histochem Cytobiol. 46:257–267.
2008. View Article : Google Scholar : PubMed/NCBI
|
33
|
Lin L, Ling BD and Li XZ: Distribution of
the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and
class 1 integron genes in multiple-antimicrobial-resistant clinical
isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus
complex. Int J Antimicrob Agents. 33:27–32. 2009. View Article : Google Scholar : PubMed/NCBI
|
34
|
Hou PF, Chen XY, Yan GF, Wang YP and Ying
CM: Study of the correlation of imipenem resistance with efflux
pumps AdeABC, AdeIJK, AdeDE and AbeM in clinical isolates of
Acinetobacter baumannii. Chemotherapy. 58:152–158. 2012. View Article : Google Scholar : PubMed/NCBI
|
35
|
Magnet S, Courvalin P and Lambert T:
Resistance-nodulation-cell division-type efflux pump involved in
aminoglycoside resistance in Acinetobacter baumannii strain BM4454.
Antimicrob Agents Chemother. 45:3375–3380. 2001. View Article : Google Scholar : PubMed/NCBI
|
36
|
Zhou Y, Wu X, Zhang X, Hu Y, Yang X, Yang
Z and Wang M: Genetic Characterization of ST195 and ST365
Carbapenem-Resistant Acinetobacter baumannii Harboring blaOXA-23 in
Guangzhou, China. Microb Drug Resist. 21:386–390. 2015. View Article : Google Scholar : PubMed/NCBI
|